Delivery Order SPE2DB20D1100-SPE2DB25FC9U5
- Not listed
- The Defense Logistics Agency awarded a $1,571.97 delivery order to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drop (2ML) on September 26, 2025, with completion scheduled for September 29, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,047.98 for VEVYE 0.1% eye drop solution (2ml) on September 25, 2025, with completion scheduled for September 26, 2025. This firm fixed-price contract represents a non-competitive, non-set-aside award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drop solution (2ml) on June 2, 2025, with a ceiling value of $2,897. This is a firm fixed price, non-set-aside delivery order under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion and extending through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,041.80 to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of VEVYE 0.1% eye drop solution in 2ML units. This is a firm fixed-price delivery order with an ultimate completion date of September 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to compete in...
- The Defense Logistics Agency awarded a $1,765.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drop solution (2ML) on July 21, 2025, with completion expected by July 22, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order valued at $9,438.39 to AmerisourceBergen Drug Corp for VEVYE 0.1% Eye Drop (2ML) on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a $8,218.23 delivery order to AmerisourceBergen Drug Corp on May 13, 2025, for the supply of VEVYE 0.1% eye drops in 2ml quantities. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of May 14, 2025. This delivery order operates under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $7,727.57 to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drops (2ML) on April 25, 2025, with an ultimate completion date of April 28, 2025. This competitively awarded, firm fixed-price delivery order was placed to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. The contract carries no set-aside designation and represents a routine pharmaceutical procurement under the company's existing contract vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $1,571.97 to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drop in 2ML units. This firm fixed price delivery order, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The contract was competitively awarded with no set-aside designation and will be performed at the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drop (2ML) with a ceiling value of $1,715.49 under a firm fixed price contract. The award was made on August 5, 2025, with an ultimate completion date of August 6, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the contractor's capability to meet federal...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FC9U5Delivery Order
The Defense Logistics Agency awarded a $1,105.62 firm fixed price delivery order to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drops (2ml) on June 18, 2025, with an ultimate completion date of June 20, 2025. This non-set-aside contract was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement needs across the Defense Health System. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's contract portfolio demonstrates its capability to fulfill federal requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical devices, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 6/18/25 |